BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28147328)

  • 1. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus.
    Liu Y; Dai L; Liu W; Shi G; Zhang J
    J Immunol Res; 2015; 2015():963568. PubMed ID: 26090506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
    Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
    Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
    Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
    Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
    Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
    Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
    Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
    J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
    Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury.
    Jin Y; Li J; Chen J; Shao M; Zhang R; Liang Y; Zhang X; Zhang X; Zhang Q; Li F; Cheng Y; Sun X; He J; Li Z
    J Immunol Res; 2019; 2019():3642937. PubMed ID: 31205955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seronegative patients with primary Sjögren's syndrome and non-pSS sicca test positive for anti-SSA/Ro52 and -Ro60 in saliva.
    Kamounah S; Wei F; Park JK; Song YW; Chia D; Wong DTW; Pedersen AML
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167168. PubMed ID: 38641012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
    Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
    Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands.
    Alunno A; Caneparo V; Carubbi F; Bistoni O; Caterbi S; Gariglio M; Bartoloni E; Landolfo S; Gerli R
    Reumatismo; 2015 Dec; 67(3):85-90. PubMed ID: 26876186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.